Authors randomly allocated 1,385 participants to four groups --- 551 to GMRx2, 276 to telmisartan–indapamide, 282 to telmisartan–amlodipine, and 276 to amlodipine–indapamide groups ...

An upcoming clinical trial will test whether empagliflozin might be able to improve heart health in pulmonary arterial ...

Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg have an estimated market size of US$ 28.2 ...

The ASA has published the first updated guideline for primary stroke prevention in 10 years. Its recommendations align with ...

Diltiazem Hydrochloride is prescribed to treat hypertension (high blood pressure) and chronic stable angina (chest pain).

Alembic Pharmaceuticals has announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride ...

High blood pressure, or hypertension, affects over 1.5 billion people worldwide and is a leading cause of heart disease and ...

When you think of arthritis, achy, warm, swollen joints probably come to mind. These are indeed some of the most common ...

Snoring can eventually lead to medical problems such as hypertension, type 2 diabetes, heart disease and stroke ...

Glaucoma is a lifelong eye disease that requires regular treatment. For many, it can be controlled by a daily eye drop ...

A combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ...

At the Neurocritical Care Society's (NCS) 22nd Annual Meeting this week, a University of Cincinnati researcher presented ...